Chet E. Holterman
Impact in
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
- Nephrology 13
- Chronic Kidney Disease and Diabetes 9
- Renal Diseases and Glomerulopathies 8
- Co-authors
- C. Kennedy (27 shared papers)Michael A. Rudnicki (3 shared papers)Josianne Payette (4 shared papers)Aleksandra Franovic (4 shared papers)Stephen Lee (3 shared papers)Jean-François Thibodeau (15 shared papers)Rhian M. Touyz (9 shared papers)Dylan Burger (9 shared papers)
- Journals
- Clinical Science (3 papers)Journal of the American Society of Nephrology (3 papers)Antioxidants and Redox Signaling (3 papers)PLoS ONE (3 papers)Diabetes (2 papers)
- Partner nations
- CanadaUnited KingdomAustralia
In The Last Decade
Chet E. Holterman
36 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 94
- Nephrology 268
- Cancer Research 307
- Clinical Biochemistry 122
- Molecular Biology 949
- Biochemistry 90
Countries citing papers authored by Chet E. Holterman
This map shows the geographic impact of Chet E. Holterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chet E. Holterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chet E. Holterman more than expected).
Fields of papers citing papers by Chet E. Holterman
This network shows the impact of papers produced by Chet E. Holterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chet E. Holterman. The network helps show where Chet E. Holterman may publish in the future.
Co-authors
The 25 scholars most cited alongside Chet E. Holterman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 255 | |
| 2 | 2017 | 121 | |
| 3 | 2009 | 117 | |
| 4 | 2014 | 113 | |
| 5 | 2005 | 111 | |
| 6 | 2013 | 110 | |
| 7 | 2014 | 84 | |
| 8 | 2018 | 77 | |
| 9 | 2007 | 75 | |
| 10 | 2014 | 73 | |
| 11 | 2004 | 63 | |
| 12 | 2018 | 52 | |
| 13 | 2014 | 47 | |
| 14 | 2022 | 41 | |
| 15 | 2019 | 40 | |
| 16 | 2014 | 35 | |
| 17 | 1998 | 35 | |
| 18 | 2018 | 29 | |
| 19 | 2014 | 24 | |
| 20 | 2010 | 15 |
About Chet E. Holterman
Chet E. Holterman is a scholar working on Molecular Biology, Nephrology, Genetics, Physiology and Cardiology and Cardiovascular Medicine, having authored 36 papers that have together received 1.6k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (9 papers), Renal Diseases and Glomerulopathies (8 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (7 papers), Nitric Oxide and Endothelin Effects (7 papers), Genetic and Kidney Cyst Diseases (4 papers), Advanced Glycation End Products research (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Renin-Angiotensin System Studies (3 papers). The work is most often cited by research in Nephrology (268 citations), Cancer Research (307 citations), Clinical Biochemistry (122 citations), Molecular Biology (949 citations) and Biochemistry (90 citations). Chet E. Holterman has collaborated with scholars based in Canada, United Kingdom and Australia. Frequent co-authors include C. Kennedy, Michael A. Rudnicki, Josianne Payette, Aleksandra Franovic, Stephen Lee, Jean-François Thibodeau, Rhian M. Touyz, Dylan Burger, James Uniacke and Gabriel Lachance. Their work appears in journals such as Clinical Science, Journal of the American Society of Nephrology, Antioxidants and Redox Signaling, PLoS ONE and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.